Rheumatoid Arthritis Clinical Trials in Los Angeles

Showing 621-640 of 3,190 trials

Study of SX-682 Plus Enzalutamide in Men With ARPI-Resistant Metastatic Castration Resistant Prostate Cancer

NCT06228053

The goal of this clinical trial is to study the combination of SX-682 plus enzalutamide in men with metastatic castration resistant prostate cancer (mCRPC) who have failed prior therapy with androgen receptor pathway inhibitors.

Metastatic Castration-resistant Prostate Cancer

Syntrix Biosystems, Inc.53 participantsStarted Nov 2024

Los Angeles, California, United States • San Francisco, California, United States • Ann Arbor, Michigan, United States +3 more locations

COMPLETEDPhase 3< 1 mile

A Study of Vericiguat (MK-1242) in Participants With Chronic Heart Failure With Reduced Ejection Fraction (HFrEF) (MK-1242-035)

NCT05093933

The purpose of this study is to evaluate the efficacy and safety of vericiguat in participants with chronic heart failure with reduced ejection fraction (HFrEF), specifically those with symptomatic chronic HFrEF who have not had a recent hospitalization for heart failure or need for outpatient intravenous (IV) diuretics. The primary hypothesis is that vericiguat is superior to placebo in reducing the risk of cardiovascular death or heart failure hospitalization.

Chronic Heart Failure With Reduced Ejection Fraction

Merck Sharp & Dohme LLC6,106 participantsStarted Nov 2021

Alexander City, Alabama, United States • Birmingham, Alabama, United States • Huntsville, Alabama, United States +516 more locations

Study of SX-682 Plus Enzalutamide in Men With ARPI-Resistant Metastatic Castration Resistant Prostate Cancer

A Study of Vericiguat (MK-1242) in Participants With Chronic Heart Failure With Reduced Ejection Fraction (HFrEF) (MK-1242-035)

Rheumatoid Arthritis Trials in Other Cities

A Study to Test if Fremanezumab is Effective in Preventing Chronic Migraine in Participants 6 to 17 Years of Age

The Effects of Very Brief Exposure on PTSD in U.S. Combat Veterans

Product Performance Report: Evaluate Long-term Reliability & Performance of Medtronic Marketed Cardiac Therapy Products

Phase 3 Study of Pelabresib (CPI-0610) in Myelofibrosis (MF) (MANIFEST-2)

Efficacy and Safety Study of Rimegepant in Episodic Migraine Prevention With Multiple Dosing Regimens

A Study To Evaluate The Efficacy, Safety, Pharmacokinetics, And Pharmacodynamic Effects Of GDC-6599 In Patients With Chronic Cough

Clinical Study of Cannabidiol in Children, Adolescents, and Young Adults With Fragile X Syndrome

Evaluating The Safety and Effectiveness of The NeoDisc™ Versus ACDF in Subjects With Single-Level Cervical Disc Disease

Basket Study of Tucatinib and Trastuzumab in Solid Tumors With HER2 Alterations

First-in-human Study of SAR443579 Infusion in Male and Female Children and Adult Participants With Relapsed or Refractory Acute Myeloid Leukemia (R/R AML), B-cell Acute Lymphoblastic Leukemia (B-ALL), High Risk-myelodysplasia (HR-MDS), or Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN)

Lisocabtagene Maraleucel, Nivolumab and Ibrutinib for the Treatment of Richter's Transformation

A Study to Evaluate the Safety, Pharmacokinetics, Pharmacodynamics, and Antitumor Activity of INV-9956 in Adult Patients With Advanced Metastatic Castration Resistant Prostate Cancer

Effects of Mouthrinse on the Microbiome of the Oral Cavity and GI Tract

An Extension Study for Treatment of Moderately to Severely Active Ulcerative Colitis

A Multicenter, Prospective Blood Collection Study in a Kidney Transplant Population

Spreading Depolarizations in Traumatic Brain Injury

Study of Nivolumab and Ipilimumab in Children and Young Adults With INI1-Negative Cancers

CBT-I vs. MBTI for Traumatic Brain Injury (TBI)-Related Insomnia and Post-Traumatic Stress Symptoms

Other Conditions in Los Angeles